{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T04:13:07Z","timestamp":1691208787128},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch med Wochenschr"],"DOI":"10.1055\/s-2002-20427","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T04:39:20Z","timestamp":1497587960000},"page":"451-456","source":"Crossref","is-referenced-by-count":0,"title":["Der selektive Tyrosinkinase-Inhibitor \nImatinib (STI571) bei h\u00e4matologischen und onkologischen \nErkrankungen"],"prefix":"10.1055","volume":"127","author":[{"given":"A","family":"Hochhaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2002,2,28]]},"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-2002-20427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T15:47:00Z","timestamp":1691164020000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-2002-20427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,28]]},"references-count":0,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2002,2,28]]},"published-print":{"date-parts":[[2002,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-2002-20427","relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,28]]}}}